True Velocity, Inc./DE (NASDAQ:YDES) is now covered by analysts at
Weiss Ratings. They set a "sell (d+)" rating on the stock.
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics